XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Segment reporting (Tables)
 9 Months Ended
May 31, 2019
Segment Reporting [Abstract]  
Reconciliation of Operating Income (Loss) from Segments to Consolidated
The following table reflects results of operations and reconciles adjusted operating income to operating income for the Company's reportable segments (in millions):

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations1
 
Walgreens
Boots
Alliance, Inc.
Three months ended May 31, 2019
 
 
 
 
 
 
 
 
 
Sales
$
26,513

 
$
2,776

 
$
5,865

 
$
(563
)
 
$
34,591

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,286

 
$
165

 
$
265

 
$
1

 
$
1,717

Acquisition-related amortization
 

 
 

 
 

 
 

 
(127
)
Transformational cost management
 

 
 

 
 

 
 

 
(86
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(80
)
Adjustments to equity earnings in AmerisourceBergen
 
 
 
 
 
 
 
 
(137
)
Store optimization
 
 
 
 
 
 
 
 
(49
)
LIFO provision
 

 
 

 
 

 
 

 
(29
)
Certain legal and regulatory accruals and settlements
 

 
 

 
 

 
 

 
(7
)
Operating income
 

 
 

 
 

 
 

 
$
1,203

 
 
 
 
 
 
 
 
 
 
Three months ended May 31, 2018
 

 
 

 
 

 
 

 
 

Sales
$
25,917

 
$
2,995

 
$
5,965

 
$
(543
)
 
$
34,334

 
 
 
 
 
 
 
 
 
 
Adjusted operating income3
$
1,492

 
$
193

 
$
258

 
$
—

 
$
1,943

Acquisition-related amortization
 
 
 
 
 
 
 
 
(131
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(57
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(60
)
Store optimization
 
 
 
 
 
 
 
 
(24
)
LIFO provision
 
 
 
 
 
 
 
 
(69
)
Certain legal and regulatory accruals and settlements2
 

 
 

 
 

 
 

 
(5
)
Operating income3
 

 
 

 
 

 
 

 
$
1,597




 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations1
 
Walgreens
Boots
Alliance, Inc.
Nine months ended May 31, 2019
 
 
 
 
 
 
 
 
 
Sales
$
78,491

 
$
8,759

 
$
17,311

 
$
(1,649
)
 
$
102,912

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
4,119

 
$
553

 
$
710

 
$
1

 
$
5,384

Acquisition-related amortization
 

 
 

 
 

 
 

 
(373
)
Transformational cost management
 

 
 

 
 

 
 

 
(265
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(228
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(191
)
Store optimization
 

 
 

 
 

 
 

 
(99
)
LIFO provision
 
 
 
 
 
 
 
 
(77
)
Certain legal and regulatory accruals and settlements
 
 
 
 
 
 
 
 
(31
)
Operating income
 

 
 

 
 

 
 

 
$
4,120

 
 
 
 
 
 
 
 
 
 
Nine months ended May 31, 2018
 

 
 

 
 

 
 

 
 

Sales
$
72,884

 
$
9,395

 
$
17,438

 
$
(1,622
)
 
$
98,095

 
 
 
 
 
 
 
 
 
 
Adjusted operating income3
$
4,520

 
$
674

 
$
714

 
$
1

 
$
5,909

Acquisition-related amortization
 

 
 

 
 

 
 

 
(329
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(173
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(136
)
Store optimization
 

 
 

 
 

 
 

 
(24
)
LIFO provision
 

 
 

 
 

 
 

 
(166
)
Certain legal and regulatory accruals and settlements2
 

 
 

 
 

 
 

 
(120
)
Asset recovery
 
 
 
 
 
 
 
 
15

Hurricane-related costs
 
 
 
 
 
 
 
 
(83
)
Operating income3
 
 
 
 
 
 
 
 
$
4,893



1 
Eliminations relate to intersegment sales between the Pharmaceutical Wholesale and the Retail Pharmacy International segments.
2 
As previously disclosed, beginning in the quarter ended August 31, 2018, management reviewed and refined its practice to include all charges related to the matters included in certain legal and regulatory accruals and settlements. In order to present non-GAAP measures on a consistent basis for fiscal year 2018, the Company included adjustments in the quarter ended August 31, 2018 of $14 million, $50 million and $5 million which were previously accrued in the Company’s financial statements for the quarters ended November 30, 2017, February 28, 2018 and May 31, 2018, respectively. These additional adjustments impact the comparability of such results to the results reported in prior and future quarters.
3 
The Company adopted new accounting guidance in Accounting Standards Update 2017-07 as of September 1, 2018 (fiscal 2019) on a retrospective basis for the Consolidated Condensed Statements of Earnings presentation. See note 17, new accounting pronouncements, for further information.